Article
A novel tumor cell line cloned from mutated human embryonic bone marrow mesenchymal stem cells.
Oncology reports - 1 Sept 2004
Xu Wenrong, Qian Hui, Zhu Wei, Chen Yongchang, Shao Qixiang, Sun Xiaochun, Hu Jiabo, Han Chongxu, Zhang Xiran
Abstract excerpt
A novel tumor cell line, denominated F6, was established from mutated human embryonic bone marrow mesenchymal stem cells (MSCs) which were induced by the GM-CSF and IL-4 in vitro. The characteristics of the F6 cell line, such as surface antigens, cell cycle, growth curve, gene expression, morphology, cytogenetics and tumor model were analyzed. The F6 cells were round and grew suspended in a plastic dish. The cell...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.